1-9 of 9
Charles J. Ryan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 445: Genomic characteristics and response to rucaparib and enzalutamide in the phase 1b RAMP study of metastatic castration-resistant prostate cancer (mCRPC) patients

Arpit Rao, Charles J. Ryan, David Morris, Vasileios Assikis, Gautam Jha, Adriel-John Ablaza, Jenn Habeck, Andrea Loehr, Jim Xiao, Esha A. Gangolli
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 445.
https://doi.org/10.1158/1538-7445.AM2021-445
Published: 01 July 2021
View article titled, Abstract 445: Genomic characteristics and response to rucaparib and enzalutamide in the phase 1b RAMP study of metastatic castration-resistant prostate cancer (mCRPC) patients
Journal Articles

Abstract LB-212: IMAAGEN study biomarker analysis in patients with long term response to abiraterone acetate with prednisone for non-metastatic castrate resistant prostate cancer

Olesya Chornoguz, Dong Shen, Gurpreet Kapoor, Weimin Li, Jennifer Phillips, Charles J. Ryan, E David Crawford, Neal D. Shore, Willie Underwood, Mary-Ellen Taplin, Philip W. Kantoff, Tracy McGowan
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-212.
https://doi.org/10.1158/1538-7445.AM2018-LB-212
Published: 01 July 2018
View article titled, Abstract LB-212: IMAAGEN study biomarker analysis in patients with long term response to abiraterone acetate with prednisone for non-metastatic castrate resistant prostate cancer
Journal Articles

Abstract B06: Characterizing the effects of hypoxia and hydrostatic pressure on the expression of immunotherapeutic targets in prostate cancer cell lines and donor immune cells in culture

Bruce A. Adams, James Lim, Tianna Chow, Susan Bernstein, Charles J. Ryan
Journal: Cancer Research
Cancer Res (2016) 76 (15_Supplement): B06.
https://doi.org/10.1158/1538-7445.TME16-B06
Published: 28 July 2016
View article titled, Abstract B06: Characterizing the effects of hypoxia and hydrostatic pressure on the expression of immunotherapeutic targets in prostate cancer cell lines and donor immune cells in culture
Journal Articles

Abstract LB-327: Isolation and mRNA-seq analysis of single CTCs from blood samples using an integrated fluidic circuit for functional single cell studies

Lukasz Szpankowski, Gayatri Premasekharan, Naveen Ramalingam, Chad Sanada, Anne Leyrat, Brian Fowler, Matthew Edwards, Cassandra Greene, Ilona Holcomb, Charles J. Ryan, Pamela L. Paris, Jay A.A. West
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-327.
https://doi.org/10.1158/1538-7445.AM2016-LB-327
Published: 15 July 2016
View article titled, Abstract LB-327: Isolation and mRNA-seq analysis of single CTCs from blood samples using an integrated fluidic circuit for functional single cell studies
Journal Articles

Abstract 931: Enrichment and characterization of propagating circulating tumor cells from late stage prostate and pancreatic cancer patients

James I. Lim, Charles J. Ryan, Thomas Krahn, Nikolas H. Stoecklein, Johannes Fischer, Bruce Adams
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 931.
https://doi.org/10.1158/1538-7445.AM2015-931
Published: 01 August 2015
View article titled, Abstract 931: Enrichment and characterization of propagating circulating tumor cells from late stage prostate and pancreatic cancer patients
Journal Articles

Abstract CT134: Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment

Dana E. Rathkopf, Matthew R. Smith, Emmanuel S. Antonarakis, Charles J. Ryan, William R. Berry, Neal D. Shore, Glenn Liu, Celestia Higano, Joshi J. Alumkal, Ralph Hauke, Ronald Tutrone, Mansoor Saleh, Edna Chow Maneval, Shibu Thomas, Deborah Ricci, Margaret K. Yu, Carla J. de Boer, Angela Trinh, Thian Kheoh, Rajesh Bandekar, Howard I. Scher
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): CT134.
https://doi.org/10.1158/1538-7445.AM2015-CT134
Published: 01 August 2015
View article titled, Abstract CT134: Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment
Journal Articles

Abstract CT239: ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (AA)

Dana E. Rathkopf, Emmanuel S. Antonarakis, Neal D. Shore, Ronald Tutrone, Joshi J. Alumkal, Charles J. Ryan, Mansoor N. Saleh, Ralph J. Hauke, Rajesh Bandekar, Edna Chow Maneval, Carla de Boer, Mary Todd, Margaret K. Yu, Howard I. Scher
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT239.
https://doi.org/10.1158/1538-7445.AM2014-CT239
Published: 01 October 2014
View article titled, Abstract CT239: ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (AA)
Journal Articles

Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer

Terence W. Friedlander, Ritu Roy, Scott A. Tomlins, Vy T. Ngo, Yasuko Kobayashi, Aruna Azameera, Mark A. Rubin, Kenneth J. Pienta, Arul Chinnaiyan, Michael M. Ittmann, Charles J. Ryan, Pamela L. Paris
Journal: Cancer Research
Cancer Res (2012) 72 (3): 616–625.
https://doi.org/10.1158/0008-5472.CAN-11-2079
Published: 31 January 2012
View article titled, Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
Open the PDF for Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF

Lawrence Fong, Serena S. Kwek, Shaun O'Brien, Brian Kavanagh, Douglas G. McNeel, Vivian Weinberg, Amy M. Lin, Jonathan Rosenberg, Charles J. Ryan, Brian I. Rini, Eric J. Small
Journal: Cancer Research
Cancer Res (2009) 69 (2): 609–615.
https://doi.org/10.1158/0008-5472.CAN-08-3529
Published: 15 January 2009
View article titled, Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
Open the PDF for Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF in another window